Jobs
View more job listings or post a job
Bioduro-Sundia Associate Director/Director in Laboratory Animal and Exploratory Toxicology
Variant Bio (Senior) Scientist - DMPK
Alturas Analytics Scientist 1
University of California, Davis TOXICOLOGY ANALYTICAL CHEMIST (STAFF RESEARCH ASSOCIATE 3)
University of California, Davis CALIFORNIA ANIMAL HEALTH AND FOOD SAFETY LABORATORY - TOXICOLOGY LAB RESEARCH SUPERVISOR/GROUP LEADER
Eli Lilly and Company R-39973 Scientific Director ADME - Novel Modalities (Open)
FibroGen Director DMPK
Applied BioMath Technical Marketing Specialist
Horizon Therapeutics Director, Bioanalytical Sciences
Exelixis Principal Scientist - DMPK
Post a job


Position:
Director of PK and TK

Employer:
Bioduro-Sundia

Description:

Responsibility: 

 

  • Lead to design, conduct and report pharmacokinetics (PK), toxicokinetics (TK), tissue distribution and excretion studies including study designs in small and large animals, LC-MS/MS bioanalytical method development, sample analysis, data modeling and analysis, reporting and interpretation.
  • Lead the bioanalytical method development and non-GLP validation of LC-MS/MS methods for discovery and regulatory PK/TK studies.
  • Direct IND-enabling PK/TK studies including study protocol, report and writing and review according to regulatory technical guidelines (US FDA, China NMPA, EMA) under a GLP-like setting.
  • Develop new PK assays as needed to address specific project or study issues, or new service capability.  
  • Keeps up to date with emerging new mass spectrometric technologies, new animal surgery and formulation delivery technologies, and regulatory technical guidelines.
  • Communicate effectively with clients for study update, project management and technical support.
  • Communicate effectively with functional groups or departments. Set priority for the lab and allocate appropriate human resources/work schedule to ensure timely report delivery.


Qualifications/Experience:

Qualifications

  • A M.S., or Ph.D. degree in drug metabolism, pharmaceutical science, organic chemistry, analytical chemistry, biochemistry, or related discipline with 8 - 15 years’ experience in pharmaceutical and biotechnological companies, or contract research organizations.
  • Hands-on experience in designing, conducting, analyzing and reporting PK, TK, tissue distribution and excretion studies to support preclinical projects in discovery and GLP-like settings.
  • Working experience in designing and conducting IND-enabling PK/TK studies to support China and US NMPA regulatory filing in a GLP-like setting.
  • A thorough understanding in formulations, cassette-dosing, dose administration routes (oral, intravenous bolus and infusion, intraarterial, intramuscular, intraperitoneal, intratracheal, subcutaneous, transdermal, oropharyngeal aspiration, intrarectal, intranasal, etc.) and special delivery of test compounds in various small and large animal species (mice, rats, dogs, monkeys, rabbits, mini-pigs, etc.) and various surgery technologies (bile-duct cannulation, jugular cannulation, portal vein cannulation, carotid artery cannulation, etc.) in PK/TK studies.
  • Expertise in LC-MS/MS quantitation techniques including various MS/MS and LC platforms especially AB Sciex MS/MS, Shimazu and Waters HPLC/UPLC, bioanalytical method troubleshooting.
  • Experience in leading and supervising a group of lab scientists.
  • Excellent oral and written communication, interpersonal, and organizational skills is required, along with demonstrated ability to interface effectively with clients and project team members.


Location: Shanghai China

Contact: mary.zeng@bioduro-sundia.com

Post Date: 6/10/2021 8:03:10 PM
©Pharmaceutical & BioScience Society, International; Last Modified: 3/28/2024; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

Alturas Analytics, Inc. Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
Lena Biosciences Predictive toxicology. Mitochondrial toxicity in a drug metabolism-competent model with active transporters. Intrinsic & idiosyncratic DILI.
Submit a Text Ad